DERM - Dermira Inc Stock Price, Fair Value and News

$5.20-0.15 (-2.80%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

DERM Price Action

Last 7 days

1.6%

Last 30 days

-17.7%

Last 90 days

15.3%

Trailing 12 Months

20.7%

DERM RSI Chart

DERM Valuation

Market Cap

106.8M

Price/Earnings (Trailing)

-5.82

Price/Sales (Trailing)

1.85

EV/EBITDA

-6.18

Price/Free Cashflow

-3.83

DERM Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

DERM Fundamentals

DERM Revenue

Revenue (TTM)

57.8M

Rev. Growth (Yr)

-57.64%

Rev. Growth (Qtr)

-1.52%

DERM Earnings

Earnings (TTM)

-18.3M

Earnings Growth (Yr)

-114.24%

Earnings Growth (Qtr)

28.89%

DERM Profitability

Operating Margin

57.32%

EBT Margin

-31.52%

Return on Equity

-167.82%

Return on Assets

-28.63%

Free Cashflow Yield

-26.1%

DERM Investor Care

Shares Dilution (1Y)

11.52%

Diluted EPS (TTM)

-0.87

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	80.0M	77.7M	57.8M	0
2023	62.6M	61.5M	79.9M	79.2M
2022	75.7M	78.7M	75.2M	73.7M
2021	49.2M	53.8M	58.5M	63.1M
2020	0	0	0	44.5M

Get all data in R, Python etc through our Historical Stock Data APIs

About Dermira Inc

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Zilxi, a topical minocycline treatment for inflammatory lesions; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.

CEO	Mr. Claude Maraoui
WEBSITE	https://journeymedicalcorp.com
SECTOR	Healthcare
INDUSTRY	Drug Manufacturers Specialty & Generic
EMPLOYEES	20

Dermira Inc Frequently Asked Questions

What is the ticker symbol for Dermira Inc? What does DERM stand for in stocks?

DERM is the stock ticker symbol of Dermira Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Dermira Inc (DERM)?

As of Wed Nov 20 2024, market cap of Dermira Inc is 106.8 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DERM stock?

You can check DERM's fair value in chart for subscribers.

Is Dermira Inc a good stock to buy?

The fair value guage provides a quick view whether DERM is over valued or under valued. Whether Dermira Inc is cheap or expensive depends on the assumptions which impact Dermira Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DERM.

What is Dermira Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Nov 20 2024, DERM's PE ratio (Price to Earnings) is -5.82 and Price to Sales (PS) ratio is 1.85. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DERM PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Dermira Inc's stock?

In the past 10 years, Dermira Inc has provided -0.108 (multiply by 100 for percentage) rate of return.